Hazard Hub
Labelling Recalls in Canada — Page 2
73 recalls involving labelling — most are health products recalls. Newest first, updated daily from government open data.
Showing 31–60 of 73
Option+ Probiotic for Adults: incorrect NPN
Labelling
View recall details →
Dexmedetomidine Hydrochloride Injection: illegible lot number and expiry date on label
Labelling
View recall details →
Con-Cret: Affected lots are labelled with the incorrect amount of medicinal ingredient
Labelling
View recall details →
JAMP Venlafaxine XR 37.5 mg capsules; Mislabelling
Labelling
View recall details →
Certain bottles of JAMP Venlafaxine XR 37.5 mg capsules recalled due to mislabelling that could lead to overdose
Labelling
View recall details →
Nature’s Bounty Kids Multivitamin Gummies recalled due to missing label information that could create a choking hazard for children under four years old
Labelling
View recall details →
Nature's Bounty Kids Multivitamin Gummies; Labelling issue
Labelling
View recall details →
Solarcaine first aid spray; Labelling issue
Labelling
View recall details →
SM Nutrition Saffron Extract Max; Labelling issue
Labelling
View recall details →
Vital Vision Plus Omega 3: Incorrect label for pediatric subpopulation
Labelling
View recall details →
COMIRNATY Original & Omicron BA.4/BA.5 Bivalent Vaccine with English-only Vial and Carton Labels: New Formulation for Use in Children 5 to Less Than 12 Years of Age
Labelling - Packaging - Product safety - Supply - COVID
View recall details →
Teva-Atenolol; Product label image incorrect
Labelling
View recall details →
SPIKEVAX Bivalent (Original / Omicron BA.4/5) (elasomeran/davesomeran) COVID-19 Vaccine with English-only Vial and Carton Labels
Labelling - Packaging - Product safety - Supply - COVID
View recall details →
Canadian labelling for all JAK inhibitors to include risks of serious heart-related problems, fatal blood clots and cancer
Labelling
View recall details →
POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION: Affected lot is labelled with the incorrect strength and ingredient
Labelling
View recall details →
COMIRNATY Original & Omicron BA.4/BA.5 Bivalent Vaccine with English-only Vial and Carton Labels
Labelling - Packaging - Product safety - Supply - COVID
View recall details →
Riva-Oxazepam: Incorrect label (Riva-Oxazepam 30MG 500 tablets DIN00568414) may be appended to affected lots that contains: Riva-Oxazepam 15MG 500 tablets DIN00568406
Labelling
View recall details →
Distribution of SPIKEVAX Bivalent (elasomeran/imelasomeran) COVID-19 Vaccine with English-only Vial and Carton Labels
Labelling - Packaging - Product safety - COVID
View recall details →
JAMP ATORVASTATIN CALCIUM: Affected lot may be labelled with the incorrect strength on the label.
Dosage - Labelling
View recall details →
Recall of one lot of Jamp-Atorvastatin Calcium as some bottles may be labelled as containing 10 mg tablets, but contain 40 mg tablets
Dosage - Labelling
View recall details →
PMS-Hydromorphone: Affected lot may contain tablets that could potentially lead to overdose
Adverse reaction - Dosage - Labelling - Packaging - Product safety - Product withdrawal
View recall details →
Recall of one lot of pms-Hydromorphone due to packaging error that could potentially lead to overdose
Adverse reaction - Dosage - Labelling - Packaging - Product safety - Product withdrawal
View recall details →
Carnivor: Product not manufactured to product specifications and does not contain the required risk information.
Labelling - Product quality
View recall details →
Distribution of a New Presentation of SPIKEVAX (elasomeran) COVID-19 Vaccine (0.10 mg/mL in 2.5 mL multidose vial) with English-only Vial and Carton Labels
Labelling - Packaging - Product safety - COVID
View recall details →
N-Larg Capsules: Label does not meet Health Canada requirements
Labelling
View recall details →
Distribution of EVUSHELD (tixagevimab and cilgavimab for injection) with English-Only Vial and Carton Labels
Labelling - Supply - COVID
View recall details →
ORBAX: Labelling Issue
Labelling
View recall details →
Distribution of NUVAXOVID with English-only Vial and Carton Labels
Labelling - Product safety - Supply - COVID
View recall details →
Rapid Protectant Hand Sanitizer Gel: labelling
Labelling - COVID
View recall details →
PAXLOVID (nirmatrelvir and ritonavir) - Dosing and Dispensing in Renal Impairment, Risk of Serious Adverse Reactions Due to Drug Interactions, and English-Only Labels
Labelling - New safety information - Supply - COVID
View recall details →